NCCN Guidelines Insights: Prostate Cancer, Version 1.2021.
J Natl Compr Canc Netw
; 19(2): 134-143, 2021 02 02.
Article
em En
| MEDLINE
| ID: mdl-33545689
ABSTRACT
The NCCN Guidelines for Prostate Cancer address staging and risk assessment after a prostate cancer diagnosis and include management options for localized, regional, and metastatic disease. Recommendations for disease monitoring and treatment of recurrent disease are also included. The NCCN Prostate Cancer Panel meets annually to reevaluate and update their recommendations based on new clinical data and input from within NCCN Member Institutions and from external entities. This article summarizes the panel's discussions for the 2021 update of the guidelines with regard to systemic therapy for metastatic castration-resistant prostate cancer.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Neoplasias da Próstata
Tipo de estudo:
Diagnostic_studies
/
Etiology_studies
/
Guideline
/
Qualitative_research
/
Risk_factors_studies
Limite:
Humans
/
Male
Idioma:
En
Revista:
J Natl Compr Canc Netw
Assunto da revista:
NEOPLASIAS
Ano de publicação:
2021
Tipo de documento:
Article